Tofacitinib Represses the Janus Kinase-Signal Transducer and Activators of Transcription Signalling Pathway in Keratinocytes

Tofacitinib is a Janus kinase (JAK) inhibitor, which has shown efficacy in treating psoriasis. The mode of action of tofacitinib is not completely understood but it has been thought to be mediated by the inhibition of CD4+ T-cell activation. Here, we investigated whether the molecular targets of tof...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Ankit Srivastava (लेखक), Mona Ståhle (लेखक), Andor Pivarcsi (लेखक), Enikö Sonkoly (लेखक)
स्वरूप: पुस्तक
प्रकाशित: Medical Journals Sweden, 2018-05-01T00:00:00Z.
विषय:
ऑनलाइन पहुंच:Connect to this object online.
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

इंटरनेट

Connect to this object online.

3rd Floor Main Library

होल्डिंग्स विवरण से 3rd Floor Main Library
बोधानक: A1234.567
प्रति 1 उपलब्ध